In pancreas recipients with advanced diabetic eye disease, conflicting ophthalmologic results over different follow-up periods have been reported. In the present prospective study we performed ophthalmologic evalua tion groups of type I diabetic patients: 1) normoglycemic recipients of pancreas and kidney grafts (group SPK, n = 43, follow-up 44.9 ±35.1 months), 2) pancreas and kidney graft recipients with nonfunctioning pancreatic graft, and recipients of isolated kidney graft (group K, n = 45, follow-up 60.3 ± 34.2 months). The examinations were performed before transplantation, at the end of follow-up (at least 1 year), and in 63 recipients also at 3 years posttransplant. Visual acuity results at baseline and at the end of follow-up were 0.48 ± 0.39 vs. 0.50 ± 0.39 in the SPK group, and 0.46 ± 0.38 vs. 0.40 + 0.39 in the K group. While intragroup changes were not significant, the changes were significantly different between the groups (p < 0.05). Fundoscopic findings at the end of follow-up were improved, stabilized, or deteriorated in the SPK group in 21.3%, 61.7%, and 17.0%, respectively. The respective figures for the K group were 6.1%, 48.8%, and 45.1% (p < 0.001). Similar results were obtained when evaluating findings at 3 years posttransplant. Before transplantation, 78% of the SPK group and 81% of the K group had been treated by laser. The need for additional posttransplant laser therapy was significantly lower in the SPK (31%) than in the K group (58%; p < 0.001). In conclusion, pancreas transplant exerts a beneficial effect on the course of diabetic retinopathy even in its late stage.
INTRODUCTION
Simultaneous pancreas and kidney transplantation is currently a standard method of treatment for patients with type I diabetes who suffer from end-stage diabetic nephropathy. While kidney transplantation eliminates the uremic syndrome, pancreas transplantation has so far been the only procedure capable of providing for longterm normoglycemia and independence of exogenous in sulin (3) . Today, while there is no doubt it improves the quality of life of the diabetic patient, its beneficial effect on microvascular disease complications of diabetes is not yet fully understood (4, 7, 11, 13) .
Advanced diabetic retinopathy is a complication as sociated, almost exclusively, with end-stage diabetic ne phropathy. Therefore, research into the effect of pan creas transplantation is often faced with the problem of an often too advanced finding, frequently after laser photocoagulation whose natural course can no longer be modulated by inducing normoglycemia.
The results of studies investigating the effect of pan creas transplantation on the development of diabetic reti nopathy were initially contradictory. The disadvantage of some trials was a too small number of patients (8, 9, 15, 18) . In the early stage of research, it was re ported successful pancreas transplantation had no impact in the course of diabetic retinopathy (9) . A number of other studies indicate stabilization of diabetic retinopa thy after pancreas transplantation (2, 6, 14, 21) . No deteri oration of diabetic retinopathy has been proved immedi ately after achieving normoglycemia following pancreas transplantation (20) . In the light of the results of these studies, the indication for transplantation treatment re mains unchanged and does not contain the anticipated beneficial effect on the development of organ complica tions of diabetes (10, 12, 16) .
The aim of the present study was to evaluate the course of advanced diabetic retinopathy in patients with type I diabetes mellitus after kidney and pancreas trans plantation, successful in the long run, and to compare the data with those of a matched group treated by kidney transplantation in combination with intensified insulin therapy. The basic characteristics of the SPK and K groups are shown in Table 1 .
SUBJECTS AND METHODS

Patient Population
Patient Assessment and Statistical Analysis
Ophthalmologic examination was performed in all re 
RESULTS
Metabolic Control
The mean values of glycosylated hemoglobin before transplantation were 9.15 ± 1.24% in the SPK group and 
Visual Acuity
In the SPK group, 12 eyes were virtually blind prior to transplantation; the figure for the K group was 7 eyes.
There 
Diabetic Retinopathy
On inclusion into the transplant program, all patients were in different stages of proliferative diabetic retinop athy, some even presented with clinically significant macular edema. Most patients had laser therapy prior to transplantation (Table 1) . No statistically significant difference in the need for laser therapy before transplan tation was found (p > 0.05).
Clinically significant macular edema (Fig. 2 ) was present equally in both groups before transplantation.
Macular edema deterioration was significantly more of ten present in the SPK group compared with the K group (p< 0.001). The findings were similar at 3 years posttransplant.
The fundoscopic finding was rated in three degrees: deteriorated, stabilized, or improved (Fig. 3) . The pro portion of eyes with stabilized or improved finding rose significantly in the SPK group compared with the K group (Fig. 3) . The results were statistically highly sig nificant. The difference in the development of diabetic retinopathy was apparent as early as 3 years from trans plantation.
Eighty percent of patients in both groups had laser therapy before transplantation. In the posttransplant pe riod, additional laser therapy was performed more often in the K group. The difference in the need for laser ther apy was similar after 3 years of follow-up (Fig. 4) . In cases where laser therapy had been indicated before transplantation and was performed within 2 months posttransplantation, it was not considered during assess ment.
Cataract
The incidence of cataract before transplantation was similar in both groups: it was present in 34.4% of the SPK group and in 23.0% of the K group. A similar trend in the finding was seen in both groups after transplanta tion. The finding deteriorated in 50.6% of patients in the SPK group, and in 47.3% of patients in the K group.
DISCUSSION
Although hyperglycemia is no doubt the underlying pathophysiological factor in the development of diabetic retinopathy (17, 19) , data on whether induction of nor moglycemia in diabetes of long-term duration may still result in stabilization or even regression of advanced le sions are conflicting (2, 5, 8, 9, 11) . Ramsay et al. 
